| Line 99: |
Line 99: |
| | | | |
| | ==Treatment== | | ==Treatment== |
| | + | |
| | + | Treatment of anticoagulant rodenticide poisoning must |
| | + | be supportive in nature and is directed at correcting the |
| | + | hypovolaemia and coagulopathy. Fresh blood or plasma |
| | + | will help to correct the hypovolaemia and enhance |
| | + | haemostasis by restoring depleted clotting factors. |
| | + | Vitamin K1 (5 mg/kg) should be given as a loading dose |
| | + | subcutaneously at multiple sites, followed by subcutaneous |
| | + | or oral doses (1.25 to 2.5 mg/kg) at eight to 12 |
| | + | hour intervals for as long as necessary (until the toxin is |
| | + | metabolised or excreted). The duration of treatment will |
| | + | depend on the anticoagulant involved. A one-week treatment |
| | + | may be undertaken initially. The PT and PTT must |
| | + | be checked 48 to 72 hours after cessation of vitamin K1 |
| | + | therapy. With the more persistent anticoagulants, these |
| | + | clotting tests may become prolonged again, indicating a |
| | + | residual toxic effect and the need for continued vitamin |
| | + | K1 therapy. In some patients, treatment for a month or |
| | + | more may be required. |
| | + | Although less expensive, vitamin K3 is relatively |
| | + | ineffective and is not recommended as a treatment for |
| | + | anticoagulant rodenticide toxicity. |
| | + | Hypocoagulable patients are at great risk of internal |
| | + | haemorrhage. Physical activity must therefore be |
| | + | minimised and their condition monitored closely. Other |
| | + | forms of supportive therapy may be indicated to reduce |
| | + | discomfort and to protect the animal from injury. The |
| | + | administration of drugs with known antiplatelet effects is |
| | + | contraindicated, as is the administration of agents by |
| | + | intramuscular injection. |
| | | | |
| | ==Prognosis== | | ==Prognosis== |